| Product Code: ETC7637025 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pediatric Vaccines Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pediatric Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pediatric Vaccines Market - Industry Life Cycle |
3.4 Ireland Pediatric Vaccines Market - Porter's Five Forces |
3.5 Ireland Pediatric Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Pediatric Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Ireland Pediatric Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Ireland Pediatric Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of pediatric vaccination in Ireland |
4.2.2 Government initiatives to promote vaccination programs for children |
4.2.3 Growing focus on prevention of infectious diseases in pediatric population |
4.3 Market Restraints |
4.3.1 High cost associated with pediatric vaccines |
4.3.2 Vaccine hesitancy among some parents in Ireland |
4.3.3 Limited access to healthcare facilities in certain remote areas |
5 Ireland Pediatric Vaccines Market Trends |
6 Ireland Pediatric Vaccines Market, By Types |
6.1 Ireland Pediatric Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pediatric Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Pediatric Vaccines Market Revenues & Volume, By Monovalent, 2021- 2031F |
6.1.4 Ireland Pediatric Vaccines Market Revenues & Volume, By Multivalent, 2021- 2031F |
6.2 Ireland Pediatric Vaccines Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pediatric Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F |
6.2.3 Ireland Pediatric Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.2.4 Ireland Pediatric Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.2.5 Ireland Pediatric Vaccines Market Revenues & Volume, By Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, 2021- 2031F |
6.3 Ireland Pediatric Vaccines Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pediatric Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3.3 Ireland Pediatric Vaccines Market Revenues & Volume, By Human Papilloma Virus, 2021- 2031F |
6.3.4 Ireland Pediatric Vaccines Market Revenues & Volume, By Measles, Mumps and Rubella, 2021- 2031F |
6.3.5 Ireland Pediatric Vaccines Market Revenues & Volume, By Meningococcal Disease, 2021- 2031F |
6.3.6 Ireland Pediatric Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.3.7 Ireland Pediatric Vaccines Market Revenues & Volume, By Polio, 2021- 2031F |
6.3.8 Ireland Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F |
6.3.9 Ireland Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F |
7 Ireland Pediatric Vaccines Market Import-Export Trade Statistics |
7.1 Ireland Pediatric Vaccines Market Export to Major Countries |
7.2 Ireland Pediatric Vaccines Market Imports from Major Countries |
8 Ireland Pediatric Vaccines Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates among children in Ireland |
8.2 Number of pediatric vaccination campaigns conducted annually |
8.3 Rate of adherence to pediatric vaccination schedules |
8.4 Number of new vaccines introduced in the pediatric market in Ireland |
8.5 Percentage of children receiving recommended vaccines on time |
9 Ireland Pediatric Vaccines Market - Opportunity Assessment |
9.1 Ireland Pediatric Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Pediatric Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Ireland Pediatric Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Ireland Pediatric Vaccines Market - Competitive Landscape |
10.1 Ireland Pediatric Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pediatric Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here